- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03622697
Effects of Mindfulness Meditation on Facial Paralysis Patients
Mindfulness Meditation to Improve Social Functioning and Quality of Life in Patients With Facial Paralysis: A Randomized Controlled Trial
Currently, physicians have several options in addressing the anatomic and physiologic sequela of facial paralysis. However, strategies to address the psychologic and coping ability for patients have not been investigated.
The goal is to investigate the effect of mindfulness meditation on social functioning in patients with facial paralysis. This study will also explore whether increasing social functioning in patients with facial paralysis will improve overall quality of life. These questions will be answered using a randomized controlled trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this study population, facial paralysis was significantly associated with increased loneliness, decreased social function, decreased comfort with socializing, and worse quality of life scores. Furthermore, prior studies have shown that facial paralysis increases the likelihood of depression as measured on validated psychometric instruments. Currently, treating physicians have several options in addressing the anatomic and physiologic sequela of facial paralysis. However, strategies to address the psychologic and coping ability for patients have not been investigated. To better provide patient-centered care, physicians should consider the psychosocial impact of facial paralysis to identify patients who may benefit from additional support interventions to complement facial reanimation treatment plans.
This is a prospective repeated measures study examining psychosocial status as measured by validated psychometric instruments. The intervention group will participate in mindfulness meditation using a phone application. Assessment of social functioning and quality of life will be conducted using survey instruments.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
Lutherville-Timonium, Maryland, United States, 21093
- Johns Hopkins - Green Spring Station
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients older than 18 years of age
- Must have any-cause facial paralysis
Exclusion Criteria:
- Patients younger than 18 years old
- Non-English speakers
- Patients without smart-phone access
- Patients with autism
- Patients with schizophrenia
- Patients with an affective psychiatric condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness Meditation Arm
Mindfulness meditation intervention: patients will be asked to complete a guided mindfulness meditation phone application intervention.
|
Mindfulness meditation intervention: patients will be asked to complete a guided mindfulness meditation intervention using a phone application for at least 4 weeks with periodic survey assessments using validated psychometric tools.
|
|
No Intervention: Non-Intervention Arm
Patients assigned to the non-intervention arm will not be instructed to use a mindfulness meditation phone application and instead will listen to educational materials.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Social Functioning as assessed by University of California, Los Angeles 3-point loneliness scale
Time Frame: Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
University of California, Los Angeles 3-point loneliness scale - minimum score 0, maximum score 100 assessing how often one feels socially isolated, higher indicating greater loneliness
|
Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
|
Changes in Social Functioning as assessed by Facial Disability Index
Time Frame: Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
Facial disability index (social functioning portion) - categorical responses ranging from "never" to "all of the time" for social problems associated with facial muscle function over the past month to measure social functioning; the minimum to maximum score range for social functioning is 5 to 30 with a higher score indicating greater social functioning
|
Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
|
Changes in Social Functioning as assessed by a Social Functioning Visual Analog Scale
Time Frame: Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
Social functioning visual analog scale - single-item questionnaire ranging from 0 to 100 with greater numbers indicating more comfort in socializing with others
|
Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Reported Quality of Life as assessed by a Visual Analog Scale
Time Frame: Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
Quality of life will be measured using the validated quality of life visual analog scale (single-item questionnaire ranging from 0 to 100 with greater numbers indicating a higher quality of life)
|
Change from baseline at 2 weeks, 4 weeks, and 6 weeks
|
|
Changes in Anxiety assessed by the State-Trait Anxiety Inventory
Time Frame: Change from baseline at 2 weeks, 4 weeks, 6 weeks
|
Anxiety will be measured using the validated State-Trait Anxiety Inventory with 20 items measuring trait anxiety and 20 items measuring state anxiety, each with categorical responses ranging from "never" to "very much so" in response statements regarding how one feels generally (trait) and at the current moment (state)
|
Change from baseline at 2 weeks, 4 weeks, 6 weeks
|
|
Changes in Mindfulness as measured using the Cognitive and Affective Mindfulness Scale-Revised
Time Frame: Change from baseline at 2 weeks, 4 weeks, 6 weeks
|
Mindfulness will be measured using the validated Cognitive and Affective Mindfulness Scale-Revised which is a 12-item questionnaire with categorical responses ranging "rarely/not at all" to "almost always" regarding statements about one's experience of mindfulness with minimum score of 12 points to a maximum score of 48 points where a higher score indicates greater mindful qualities
|
Change from baseline at 2 weeks, 4 weeks, 6 weeks
|
|
Changes in Physical Functioning as assessed by Facial Disability Index
Time Frame: Change from baseline at 2 weeks, 4 weeks, 6 weeks
|
Facial disability index (physical functioning portion) - categorical responses ranging from "usually with no difficulty" to "usually did not do because of health" for physical problems associated with facial muscle function over the past month to measure physical functioning; the minimum to maximum score range for social functioning is 0 to 25 with a higher score indicating worse physical function
|
Change from baseline at 2 weeks, 4 weeks, 6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lisa Ishii, MD, MHS, Johns Hopkins University
Publications and helpful links
General Publications
- Hoge EA, Bui E, Palitz SA, Schwarz NR, Owens ME, Johnston JM, Pollack MH, Simon NM. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res. 2018 Apr;262:328-332. doi: 10.1016/j.psychres.2017.01.006. Epub 2017 Jan 26.
- Simkin DR, Black NB. Meditation and mindfulness in clinical practice. Child Adolesc Psychiatr Clin N Am. 2014 Jul;23(3):487-534. doi: 10.1016/j.chc.2014.03.002.
- Nellis JC, Ishii M, Byrne PJ, Boahene KDO, Dey JK, Ishii LE. Association Among Facial Paralysis, Depression, and Quality of Life in Facial Plastic Surgery Patients. JAMA Facial Plast Surg. 2017 May 1;19(3):190-196. doi: 10.1001/jamafacial.2016.1462.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00135870
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Facial Paralysis
-
Rebecka OhmRecruitingFacial Palsy | Bell Palsy | Facial Paralysis | Synkinesis | Peripheral Facial Palsy | Peripheral Facial ParalysisSweden
-
Murat AkınRecruitingBell Palsy | Facial Paralysis, PeripheralTurkey
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingPeripheral Facial ParalysisChina
-
Universidad Nacional del Nordeste, ArgentinaNational Council of Scientific and Technical Research, ArgentinaRecruitingFacial Palsy | Peripheral Facial Paralysis | SynkinesesArgentina
-
Beijing Tongren HospitalCompleted
-
Federal University of São PauloCompletedFacial Nerve Diseases | Orofacial Pain | Peripheral Nerve Facial Nerve ParalysisBrazil
-
University of Campinas, BrazilCompletedPeripheral Facial ParalysisBrazil
-
Assistance Publique - Hôpitaux de ParisTerminatedUnilateral Peripheral Facial ParalysisFrance
-
Peking Union Medical College HospitalRecruiting
-
Assiut UniversityUnknownFacial Nerve ParalysisEgypt
Clinical Trials on Mindfulness Meditation Phone Application
-
Johns Hopkins UniversityTerminatedSystemic Lupus Erythematosus | Vasculitis | Inflammatory Arthritis | Myositis | Sjogren's Syndrome | SclerodermaUnited States
-
Ospedale Regionale di MendrisioRecruitingAnxiety State | Test Anxiety | Preoperative PeriodSwitzerland
-
Oregon Health and Science UniversityCompleted
-
University Hospital, AngersWithdrawnLateral Sclerosis Amyotrophy | Mindfulness Meditation
-
University of Illinois at Urbana-ChampaignNorthwestern University Feinberg School of Medicine; Southern Illinois University and other collaboratorsNot yet recruitingPain, Postoperative | Depression, Unipolar
-
Equa HealthNational Institute of Mental Health (NIMH); Worcester Polytechnic InstituteRecruitingPsychological Distress | Mindfulness Skills | Usability SatisfactionUnited States
-
Barbara L. Fredrickson, PhDNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Universiti Tunku Abdul RahmanRecruiting
-
Icahn School of Medicine at Mount SinaiTerminatedPain, Postoperative | Spine Surgery | MeditationUnited States
-
York UniversityCompletedChronic Pain | Depression, AnxietyCanada